Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice
Circulation Cardiovascular Interventions2010Vol. 3(4), pp. 327–334
Citations Over TimeTop 10% of 2010 papers
Joshua M. Stolker, Kevin F. Kennedy, Jason B. Lindsey, Steven P. Marso, Michael Pencina, Donald E. Cutlip, Laura Mauri, Neal S. Kleiman, David J. Cohen, on behalf of the EVENT Investigators
Abstract
The overall incidence of TLR remains low among unselected patients receiving DES in routine clinical practice. A simple risk model incorporating 6 readily available clinical and angiographic variables helps identify individuals at extremely low (7%) risk of TLR after DES implantation.
Related Papers
- → Serum IL-38 Level Was Associated with Incidence of MACE in the STEMI Patients(2023)3 cited
- The significance of serum NT-proBNP for the future risk evaluation of major adverse cardiac events in elderly patients with stable coronary artery disease(2013)
- Clinical study of different treatment strategy for AMI patients treated by primary PCI with multi-vessel coronary artery disease(2009)
- → PM199 Rationale, Design and Feasibility of a Nationwide Prospective Registry of Management of Acute Coronary Events (Mace) in India(2016)
- → Ten-year predictors of major adverse cardiovascular events in patients without angina(2023)